 Elise Michelle Sannar
| Title | Associate Professor |
|---|
| Institution | University of Colorado Denver - Anschutz Medical Campus |
|---|
| Department | SOM-PSYCH |
|---|
| Phone | 720/777-4964 |
|---|
|
|
|
 Research R61HD109748 (ESPINOSA, JOAQUIN M.)Sep 9, 2022 - Jun 30, 2024 NIH
Mechanistic investigation of therapies for Down Syndrome Regression Disorder
Role: Co-Principal Investigator |
Bibliographic
-
Rachubinski AL, Patel LR, Sannar EM, Kammeyer RM, Sanders J, Enriquez-Estrada BA, Worek KR, Fidler DJ, Santoro JD, Espinosa JM. JAK inhibition in Down Syndrome Regression Disorder. J Neuroimmunol. 2024 10 15; 395:578442. PMID: 39216159.
-
Sannar EM, Winter JR, Franke RK, Werner E, Rochowiak R, Romani PW, Miller OS, Bainbridge JL, Enabulele O, Thompson T, Natvig C, Mikulich-Gilbertson SK, Tartaglia NR. Cannabidiol for treatment of Irritability and Aggressive Behavior in Children and Adolescents with ASD: Background and Methods of the CAnnabidiol Study in Children with Autism Spectrum DisordEr (CASCADE) Study. medRxiv. 2024 Aug 13. PMID: 39211864.
-
Gleason E, Malik K, Sannar E, Kamara D, Serrano V, Augustyn M. Challenging Case: A Multidisciplinary Approach to Demystifying Chronic Sleep Impairment in an Infant with a Complex Medical and Behavioral Profile. J Dev Behav Pediatr. 2024 Mar-Apr 01; 45(2):e176-e179. PMID: 38290114.
-
Santoro J, Spinazzi N, Filipink R, Hayati-Rezvan P, Kammeyer R, Patel L, Sannar E, Dwyer L, Banerjee A, Khoshnood M, Jafarpour S, Boyd N, Partridge R, Gombolay G, Christy A, Real de Asua D, Del Carmen Ortega M, Manning M, Van Mater H, Worley G, Franklin C, Stanley M, Brown R, Capone G, Quinn E, Rafii M. Immunotherapy Responsiveness and Risk of Relapse in Down Syndrome Regression Disorder. Res Sq. 2023 Feb 13. PMID: 36824719.
-
Santoro JD, Patel L, Kammeyer R, Filipink RA, Gombolay GY, Cardinale KM, Real de Asua D, Zaman S, Santoro SL, Marzouk SM, Khoshnood M, Vogel BN, Tanna R, Pagarkar D, Dhanani S, Ortega MDC, Partridge R, Stanley MA, Sanders JS, Christy A, Sannar EM, Brown R, McCormick AA, Van Mater H, Franklin C, Worley G, Quinn EA, Capone GT, Chicoine B, Skotko BG, Rafii MS. Assessment and Diagnosis of Down Syndrome Regression Disorder: International Expert Consensus. Front Neurol. 2022; 13:940175. PMID: 35911905.
-
Duis J, Pullen LC, Picone M, Friedman N, Hawkins S, Sannar E, Pfalzer AC, Shelton AR, Singh D, Zee PC, Glaze DG, Revana A. Diagnosis and management of sleep disorders in Prader-Willi syndrome. J Clin Sleep Med. 2022 06 01; 18(6):1687-1696. PMID: 35172921.
-
Pennington S, Stutzman D, Sannar E. Pitolisant in an Adolescent with Prader-Willi Syndrome. J Pediatr Pharmacol Ther. 2021; 26(4):405-410. PMID: 34035686.
-
Pesko MJ, Burbige EM, Sannar EM, Beresford C, Rogers C, Ariefdjohan M, Stutzman D. The Use of N-acetylcysteine Supplementation to Decrease Irritability in Four Youths With Autism Spectrum Disorders. J Pediatr Pharmacol Ther. 2020; 25(2):149-154. PMID: 32071590.
-
Sannar EM, Palka T, Beresford C, Peura C, Kaplan D, Verdi M, Siegel M, Kaplan S, Grados M. Sleep Problems and Their Relationship to Maladaptive Behavior Severity in Psychiatrically Hospitalized Children with Autism Spectrum Disorder (ASD). J Autism Dev Disord. 2018 Nov; 48(11):3720-3726. PMID: 29086209.
-
Palat P, Hickey F, Patel L, Sannar E. Levodopa-Responsive Early-Onset Parkinsonism in Down Syndrome. Case Rep Neurol Med. 2018; 2018:2314791. PMID: 29666730.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2018 | 2 | | 2020 | 1 | | 2021 | 1 | | 2022 | 2 | | 2023 | 1 | | 2024 | 3 |
To return to the timeline, click here.
|
Sannar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|